News

Aperio Joins Florence Healthcare on Live Webinar Panel “Moving Beyond COVID"

hybrid and virtual trials

Aperio Joins Florence Healthcare on Live Webinar Panel “Moving Beyond COVID"

MAY 13, 2021

Aperio’s Suzanne Kincaid recently participated as a panelist in Florence Healthcare’s Expert Webinar Series “Moving Beyond COVID: Lessons Learned by Sponsors and CROs.” Suzanne was joined on the panel by fellow industry experts from Pfizer and Total Clinical Trial Management.

During the webinar, panelists discussed:

  • What changes they made in response to COVID disruptions to their operations
  • How they are using Florence eHub to connect to study sites with an eISF/eBinders
  • How they helped sites navigate the rapid transition
  • Where they are looking to evolve in the next 3-5 years

Miss the webinar or want to view it again? Watch here.

About Aperio Clinical Outcomes

In a data driven industry, Aperio remains dedicated to transparency with clients and focused on the most important part of the process: people. Aperio provides full, customizable clinical research services across multiple therapeutic areas, as well as consulting services in Quality Assurance, Strategic Resourcing and Clinical Trial Technology. For more information: www.aperioclinical.com


Suzanne Kincaid to Present on Managing Risk in Clinical Research at MAGI's Spring Conference

hybrid and virtual trials

Suzanne Kincaid to Present on Managing Risk in Clinical Research at MAGI's Spring 2021 Clinical Research Conference

APRIL 22, 2021

Join Aperio’s Suzanne Kincaid as she presents on a panel titled “Risky Business: Assessing, Characterizing & Managing Risk in Clinical Research” at MAGI’s Spring 2021 Clinical Research Conference.

The panel, facilitated by Dawn Niccum with inSeption Group, will discuss the foundations of risk management in clinical research; identify critical processes and data as a basis for risk identification; and review risk management tools, including dashboards and data analytics. Fellow industry experts – Maryse Brulotte with University of Utah and Katelyn Penney with St. Luke’s Health System – will join Dawn and Suzanne for the panel.

The panel takes place on Wednesday, April 28, 2021 from 11:00 AM EDT – 1:30 PM EDT.

Register to attend MAGI.

About Aperio Clinical Outcomes

In a data driven industry, Aperio remains dedicated to transparency with clients and focused on the most important part of the process: people. Aperio provides full, customizable clinical research services across multiple therapeutic areas, as well as consulting services in Quality Assurance, Strategic Resourcing and Clinical Trial Technology. For more information: www.aperioclinical.com


PharmaVoice Sits Down with Aperio's Suzanne Kincaid to Discuss Top Priorities in Clinical Research for 2021

hybrid and virtual trials

PharmaVoice Sits Down with Aperio's Suzanne Kincaid to Discuss Top Priorities in Clinical Research for 2021

APRIL 8, 2021

Check out PharmaVOICE‘s April 2021 “Trend Tracking” article and discover what Aperio’s Suzanne Kincaid and other PharmaVOICE 100 leaders had to say about their top priorities in clinical research for 2021 and leadership skills that got them through the pandemic.

Read here.

About Aperio Clinical Outcomes

In a data driven industry, Aperio remains dedicated to transparency with clients and focused on the most important part of the process: people. Aperio provides full, customizable clinical research services across multiple therapeutic areas, as well as consulting services in Quality Assurance, Strategic Resourcing and Clinical Trial Technology. For more information: www.aperioclinical.com


Cari Kniola Says Decentralized Clinical Trials Is the Next Big Game Changer

decentralized clinical trials

Cari Kniola Says Decentralized Clinical Trials Is the Next Big Game Changer

MARCH 1, 2021

Check out PharmaVOICE‘s 20th Anniversary edition and hear what Aperio’s Director of Corporate Strategy Cari Kniola has to say about the revolutionary role that data analytics has played in the clinical research industry and how patient-centric healthcare technologies and decentralized trials are the next big game changers.

Read here.

About Aperio Clinical Outcomes

In a data driven industry, Aperio remains dedicated to transparency with clients and focused on the most important part of the process: people. Aperio provides full, customizable clinical research services across multiple therapeutic areas, as well as consulting services in Quality Assurance, Strategic Resourcing and Clinical Trial Technology. For more information: www.aperioclinical.com


Faye Woolf Talks to PharmaVoice about COVID-19's Positive Impact on the Clinical Trial Industry

COVID-19 Positive Impact on Clinical Trials

Faye Woolf Talks to PharmaVoice about the Positive Impact of COVID-19 on the Clinical Trial Industry

FEBRUARY 2, 2021

Check-out PharmaVoice’s February edition of Commanders & Chiefs to see what Aperio’s Founder and CEO Faye Woolf had to say about getting back to the business of clinical trials and how COVID-19 forced the industry to adapt and adopt some much needed changes.

Read here.

About Aperio Clinical Outcomes

In a data driven industry, Aperio remains dedicated to transparency with clients and focused on the most important part of the process: people. Aperio provides full, customizable clinical research services across multiple therapeutic areas, as well as consulting services in Quality Assurance, Strategic Resourcing and Clinical Trial Technology. For more information: www.aperioclinical.com


PharmaVoice Talks to Suzanne Kincaid About the Clinical Research Industry's Shift to Hybrid and Virtual Trials

PharmaVoice Talks to Suzanne Kincaid About the Clinical Research Industry's Shift to Hybrid and Virtual Trials

SEPTEMBER 10, 2020

Suzanne Kincaid – 2020 PharmaVOICE 100 winner – speaks with PharmaVOICE Editor Taren Grom about her passion for mentoring the next generation of clinical research professionals and her thoughts on the clinical research industry’s rapid shift towards hybrid and virtual trials.

About Aperio Clinical Outcomes

In a data driven industry, Aperio remains dedicated to transparency with clients and focused on the most important part of the process: people. Aperio provides full, customizable clinical research services across multiple therapeutic areas, as well as consulting services in Quality Assurance, Strategic Resourcing and Clinical Trial Technology. For more information: www.aperioclinical.com


Stacey King to Chair Session on "Risk Based Monitoring: It Takes a Village" at the 2020 Virtual SCDM Conference

Join Aperio Clinical Outcomes' Senior Director Data Management Stacey King as she chairs a session on "Risk Based Monitoring: It Takes a Village" at the 2020 Virtual Society for Clinical Data Management (SCDM) conference. With constant changes from updated regulations to new technologies popping like popcorn, it truly takes a village to raise a product from concept to market. During this session, Mrs. King and her panel of industry experts will evaluate how Risk Based Quality Management (RBQM) is more than just risk-based monitoring, but a comprehensive approach to evaluating and monitoring overall clinical trial risks. They will discuss how the various members of the village work together to form a holistic Risk Based Quality Management (RBQM) strategy.

These distinguished panelists will join Mrs. King for her session on September 15, 2020, at 11:15 am EDT:

  • Kelly Doyle, ePRO Project Manager, PRA Health Sciences
  • Po Nam Loo, Director, Clinical Data Management, MSD R&D (China) Co., Ltd.
  • Suzanne Kincaid, Chief Operating Officer, Aperio Clinical Outcomes

Register for the 2020 Virtual SCDM Conference and learn what works, what doesn’t, and how you can implement a successful RBQM strategy for your next medical discovery.

About Aperio Clinical Outcomes

In a data driven industry, Aperio remains dedicated to transparency with clients and focused on the most important part of the process: people. Aperio provides full, customizable clinical research services across multiple therapeutic areas, as well as consulting services in Quality Assurance, Strategic Resourcing and Clinical Trial Technology. For more information: www.aperioclinical.com

Aperio Clinical Outcomes Contact:
Heather Newbold: +1 919-604-5704
[email protected]


Suzanne Kincaid Named to Distinguished 2020 PharmaVOICE 100 List of Most Inspiring People

Aperio Clinical Outcomes is thrilled to announce that Suzanne Kincaid, Chief Operating Officer for Aperio, has been named to the PharmaVOICE 100 list of Most Inspiring People in the life-sciences industry.

PharmaVOICE 100 is the only awards program to recognize individuals spanning all sectors of the life-sciences industry — from academia to nonprofit organizations to big pharma to emerging biotech companies to all types of innovative companies that provide molecule-to-market services in support of moving the needle to benefit patients around the world. The result is a dynamic mix of people across a range of disciplines who are making meaningful contributions in their fields of influence. This diverse group of individuals is also unique in that they represent a wide variety of functional areas — ranging from the clinic to the C-suite. The PharmaVOICE 100 issue recognizes its distinguished honorees across multiple categories each year. Suzanne was named to the Commanders & Chiefs category. According to PharmaVOICE, the forward-thinking leaders that are named to this category are strategically positioning their companies for success and inspiring their teams to achieve far-reaching goals as they navigate complex industry challenges.

According to Taren Grom, editor and co-founder of PharmaVOICE magazine, "When we introduced the PharmaVOICE 100 most inspiring people in the life-sciences industry more than 15 years ago it began a movement. Our goal is to capture that intangible measure of a person’s influence: inspiration. Each year, our community puts thoughtful consideration into distinguishing the individuals who are leading the charge in terms of inspired leadership, creativity, breakthrough science, corporate excellence, patient advocacy, mentorship and sponsorship, technology development, and so on — in short the individuals who are driving change and redefining the landscape of the life-sciences ecosystem."

When speaking of Suzanne's recognition, CEO Faye Woolf said "I couldn't be more proud of Suzanne. Her gift of leadership and passion for clinical research and helping raise up the next generation of clinical researchers is inspiring to all of us who work alongside her every day. What makes this recognition so special, is that we now get to share all of the great things that inspire us about Suzanne with the rest of the life-sciences industry!"

About Aperio Clinical Outcomes

In a data driven industry, Aperio remains dedicated to transparency with clients and focused on the most important part of the process: people. Aperio provides full, customizable clinical research services across multiple therapeutic areas, as well as consulting services in Quality Assurance, Strategic Resourcing and Clinical Trial Technology. For more information: www.aperioclinical.com

Aperio Clinical Outcomes Contact:
Heather Newbold: +1 919-604-5704
[email protected]


Aperio Donates to the Food Bank of Central & Eastern NC In Recognition of #GivingTuesdayNow

Aperio Clinical Outcomes has made a donation to the Food Bank of Central & Eastern NC, in recognition of #GivingTuesdayNow. #GivingTuesdayNow, held on May 5, 2020, is a day of global giving and unity in response to the unprecedented need caused by COVID-19. By participating in a virtual food drive coordinated by the Food Bank, Aperio staff raised a total of $875 to help feed families in need.

The Food Bank has seen an enormous increase in demand for food since the COVID-19 crisis began, with spending on food growing from $55,000 to over $2 million per month. In addition, the Food Bank has distributed thousands of family-sized boxes, containing 20 meals per box, to go to the Food Bank’s disaster relief partner agencies – food pantries, soup kitchens and shelters – as well as some area school districts, and several Meals on Wheels chapters. The Food Bank is also supporting numerous Grab & Go Meals for Kids locations to help support families who traditionally rely on school lunch programs throughout the year.

Consider joining the movement by making a generous donation at foodbankcenc.org.

About Aperio Clinical Outcomes

In a data driven industry, Aperio remains dedicated to transparency with clients and focused on the most important part of the process: people. Aperio provides full, customizable clinical research services across multiple therapeutic areas, as well as consulting services in Quality Assurance, Strategic Resourcing and Clinical Trial Technology. For more information: www.aperioclinical.com

Aperio Clinical Outcomes Contact:
Heather Newbold: +1 919-604-5704
[email protected]


Aperio Releases New Video Series in Honor of Clinical Trials Day 2020

Aperio Releases New Video Series in Honor of
Clinical Trials Day 2020

MAY 20, 2020

2020 has been a difficult year as the COVID-19 global pandemic has swept the globe. Seemingly overnight, our healthcare workers became heroes as they were forced to the frontlines of the battlefield and the clinical trial industry received uncommon publicity as the pressure mounted to develop vaccines and other life-saving treatments in the fight against COVID-19.

Against this backdrop, Aperio released a video series in honor of Clinical Trials Day – May 20, 2020 – and the higher calling of hundreds of thousands of clinical research professionals spanning the globe.

In the three-part video series, Aperio’s states it’s continued commitment, passion and dedication to our industry’s high calling to bring new, life-saving, life-improving treatments to patients in need.

 

Part 1: Aperio is committed to the development of groundbreaking medical treatments, improving the quality of life for patients, and providing transparency, expertise and proactive risk mitigation for our sponsors.

Part 2: Aperio is passionate about new and better medical device treatments, excellence in clinical operations, building lasting relationships with sites and approaching study quality with the end in mind.

Part 3: Aperio is dedicated to patient recruitment and engagement, rigorous standards for quality data, clinical trial innovation and offering hope for a brighter tomorrow.

About Aperio Clinical Outcomes

In a data driven industry, Aperio remains dedicated to transparency with clients and focused on the most important part of the process: people. Aperio provides full, customizable clinical research services across multiple therapeutic areas, as well as consulting services in Quality Assurance, Strategic Resourcing and Clinical Trial Technology. For more information: www.aperioclinical.com